Abstract
Co-delivery of all-trans-retinoic acid and paclitaxel using albumin-bound nanoparticles demonstrated a significantly improved anti-metastatic effect to breast cancer both in vitro and in vivo. Notably, the co-delivery nanoparticles exhibited more pronounced therapeutic effects than the combination of two free drugs or two HSA loaded single drugs.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Albumin-Bound Paclitaxel / chemistry*
-
Albumin-Bound Paclitaxel / pharmacology*
-
Animals
-
Antineoplastic Agents / chemistry*
-
Antineoplastic Agents / pharmacology*
-
Breast Neoplasms / pathology
-
Cell Line, Tumor
-
Drug Carriers / chemistry*
-
Humans
-
Mice
-
Models, Molecular
-
Nanoparticles / chemistry*
-
Neoplasm Metastasis
-
Protein Conformation
-
Tretinoin / chemistry*
Substances
-
Albumin-Bound Paclitaxel
-
Antineoplastic Agents
-
Drug Carriers
-
Tretinoin